Stock Price
74.23
Daily Change
-1.45 -1.92%
Monthly
-1.37%
Yearly
121.19%
Q2 Forecast
72.74

Ionis Pharmaceuticals reported 396.15 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Astellas Pharma 15.48 8.16 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Celltrion 67.83 17.74 Dec/2025
Cspc Pharmaceutical 24.4 1.13 Dec/2025
Deva Holding AS 6.55 2.01 Sep/2023
Divis Laboratories Ltd 66.5 5.69 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Exelixis 13.91 588.4 Mar/2026
Halozyme Therapeutics 11.35 11.8 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Kangmei Pharma 3.15K 624.19 Jun/2025
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Neurocrine Biosciences 28.09 807.38 Mar/2026
Novartis 20.17 2.32 Mar/2026
OPKO Health 40.77 7.86 Sep/2021
Organigram Holdings 235 224.49 Sep/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pfizer 9.32 5.16 Mar/2026
Pharma Mar 19.13 1.72 Mar/2026
PTC Therapeutics 9.98 3.25 Dec/2025
Qiagen NV 20.54 0.1 Dec/2025
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Dec/2025
Sartorius 43.44 84.64 Mar/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
Vertex Pharmaceuticals 25.82 0.33 Mar/2026
Zealand Pharma A/S 5.13 0.16 Dec/2025
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026